Recent Updates
Recently added Catalysts
CLNN Positive Sentiment Score: 70/100

Clene Nanomedicine to Participate in Roth’s 35th Annual Healthcare Conference and Renmark Virtual Non-Deal Roadshow Series

Tuesday, March 7, 2023 2 min read
Key Takeaway: Clene Inc. (Nasdaq: CLNN) and its subsidiary Clene Nanomedicine will participate in Roth's 35th Annual Healthcare Conference from March 12-14 and in the Renmark Virtual Non-Deal Roadshow Series on March 7 and 22. The company aims to share insights into its innovative approach to treating neurodegenerative diseases during these events. A live webcast of their presentations will be accessible through their website links. These engagements underscore Clene's efforts to connect with investors and stakeholders in the biopharmaceutical space.

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene is participating in significant healthcare conferences, indicating active engagement with investors.
  • The company's focus on neurodegenerative diseases highlights its commitment to impactful medical advancements.
  • Live Q&A sessions provide transparency and engagement with potential investors.

Full Press Release Details

SALT LAKE CITY, March 07, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, today announced that it will participate in Roth’s 35th Annual Healthcare Conference set for March 12th-14th and in Renmark Financial Communications Inc.’s Virtual Non-Deal Roadshow Series on March 7th and 22nd.
Roth 35th Annual Healthcare Conference, March 12-14
Presentation/Fireside Chat Time: March 13 starting at 3:30 p.m. E.D.T
Webcast link: https://wsw.com/webcast/roth46/clnn/1826765
The webcast of this presentation will be posted to the Investors section of the Company’s website located at www.invest.clene.com.
Renmark Virtual Non-Deal Roadshow Series
Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, will deliver the latest investor presentation followed by a live Q&A session. Individuals can register by using the link below.
March 7 – 4 p.m. EDT, https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-nasdaq-clnn-2023-03-07-130000
March 22 – 2 p.m. EDT, https://www.renmarkfinancial.com/events/renmark-virtual-non-deal-roadshow-nasdaq-clnn-2023-03-22-130000
Registration for the Renmark events may be limited but access to the replays will be posted to the Investors section of the Company’s website within a few days of the events. To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
Renmark Financial Communications Inc.
James R. Kautz: jkautz@renmarkfinancial.com
Tel.: (416) 644-2020 or (212) 812-7680
www.renmarkfinancial.com

Frequently Asked Questions

When is Clene participating in the Roth Conference?

Clene will participate in the Roth Conference from March 12 to 14, 2023.

How can I access Clene's presentation at the Roth Conference?

You can access the presentation via the webcast link provided on their website.

What dates are the Renmark Virtual Roadshow events?

The Renmark Virtual Roadshow events are on March 7 and March 22, 2023.

Who will present at the Renmark Roadshow?

Clene's CEO Rob Etherington and CFO Morgan Brown will present at the event.

Where can I find replays of the Renmark events?

Replays will be available in the Investors section of Clene's website shortly after.

Tags: CLNN Viatris Investor Conferences Healthcare Clene Inc. healthcare conference neurodegenerative diseases Renmark Financial Communications
Last updated: Mar 7, 2023